News
Videos
Conferences
Events
Resources
Subscribe

|Videos|September 27, 2017

Improving Outcomes in Bladder Cancer

Episodes in this series

EP. 1 The Warning Signs of Bladder Cancer

EP. 1 The Warning Signs of Bladder Cancer

EP. 2 Detecting Bladder Cancer

EP. 2 Detecting Bladder Cancer

EP. 3 Muscle Invasive Bladder Cancer

EP. 3 Muscle Invasive Bladder Cancer

EP. 4 What is BCG Immunotherapy?

EP. 4 What is BCG Immunotherapy?

EP. 5 Making Decisions on Bladder Removal

EP. 5 Making Decisions on Bladder Removal

EP. 6 When Plans Change During Surgery

EP. 6 When Plans Change During Surgery

EP. 7 Chemotherapy for Metastatic Bladder Cancer

EP. 7 Chemotherapy for Metastatic Bladder Cancer

EP. 8 How the Oncology Nurse Supports Patients

EP. 8 How the Oncology Nurse Supports Patients

EP. 9 Immunotherapy in Bladder Cancer

EP. 9 Immunotherapy in Bladder Cancer

EP. 10 Bladder Cancer Clinical Trials

EP. 10 Bladder Cancer Clinical Trials

EP. 11 Immunotherapy Experience in Bladder Cancer

EP. 11 Immunotherapy Experience in Bladder Cancer

EP. 12 Bladder Cancer Advocacy Network

EP. 12 Bladder Cancer Advocacy Network

EP. 13 Improving Outcomes in Bladder Cancer

EP. 13 Improving Outcomes in Bladder Cancer

EP. 14 Educational Resources and Patient Support

EP. 14 Educational Resources and Patient Support

Newsletter

Stay up to date on cancer updates, research and education

Related Content

Image of FDA

FDA Approves Keytruda-Based Combination Before and After Surgery for Muscle-Invasive Bladder Cancer

ByQuincy Attobrah

July 10th 2026

Image of Garmezy

The Most Asked Bladder Cancer Questions: Signs, Symptoms, Stages and Treatment Options

ByDr. Benjamin Garmezy

June 5th 2026

Image of FDA

FDA Approves Imfinzi Plus BCG for High-Risk Bladder Cancer

ByQuincy Attobrah

May 28th 2026

Image of Stewart

Young, Active and Healthy: Never Expecting a Bladder Cancer Diagnosis at 39

ByQuincy Attobrah

May 27th 2026

FDA

FDA Approves Tecentriq for Bladder Cancer With Detected DNA After Surgery

May 15th 2026

Trending on CURE

Dolly Parton, 80, Dies Following a Brief Battle with Cancer

FDA Approves Rasonque, First-in-Class Targeted Therapy for Metastatic Pancreatic Cancer

Oncologist Explains What the Rasonque Approval Means for Patients With Metastatic Pancreatic Cancer

What 35 Years with Polycythemia Vera Reveal About Diagnosis and Hope

How One Woman Taught Me to Live With an Incurable Cancer